Biodegradable stents are medical devices made up of bio-absorbable material such as polymer or metal used to achieve normal flow of blood or other bloodily fluids in case of clogged or narrowed vessels. The report delivers concise and clear in-depth analysis of market size and market growth under the scope product type, material type, and end users. Furthermore, report tracks the recent product launches, and trends driving the biodegradable stents market. However, report also focuses on the factors which are hindering the global biodegradable stents market growth.
Market Dynamics
Factors such as increasing product launches with biodegradable material or technologically advanced form such as completely degradable stents and increasing incidences of cardiac coronary artery disease are driving the biodegradable stents market growth. For instance, in 2016, Biotronik SE & Co. received CE approval for Magmaris, which is first clinically-proven magnesium scaffold based bioresorbable stents for the treatment of coronary artery disease. Moreover, the pipeline product are aiding to the biodegradable stents market growth over the forecast period. For instance, Scitech Produtos Medicos Ltda is conducting clinical trials for Inspiron stents and biomatrix flex stents for the coronary artery disease, which as on April 2018, was in phase 4 trial. However, the drawbacks associated with polymer such as expansion and recoiling of stents, are expected to restrain the biodegradable stents market growth.
Key features of the study:
This report provides in-depth analysis of the biodegradable stents market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global biodegradable stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global biodegradable stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of biodegradable stents, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the biodegradable stents market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
Global Biodegradable Stents Market, By Product Type:
Coronary Stents
Peripheral Stents
Global Biodegradable Stents Market, By Material Type:
Polymer-based Stents
Metallic Stents
Global Biodegradable Stents Market, By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Global Biodegradable Stents Market, By Region:
North America
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Coronary Stents
Peripheral Stents
By Material Type:
Polymer-based Stents
Metallic Stents
By End Users:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
North Africa
Central Africa
South Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Abbott
Kyoto Medical Planning Co., Ltd.
QualiMed
Elixir Medical Corporation
ENDOCOR GmbH
BIOTRONIK SE & Co. KG
Amaranth Medical, Inc.
Arterial Remodeling Technologies SA
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product Type
o Market Snippet, By Material Type
o Market Snippet, By End User
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Industry Trends
o Recent Approvals
o Regulatory Scenario
o Epidemiology
o PEST Analysis
4. Global Biodegradable Stents Market, By Product Type, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Coronary Stents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Peripheral Stents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Biodegradable Stents Market, By Material Type, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Polymer-based Stents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Metallic Stents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Biodegradable Stents Market, By End User, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Specialty Clinics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Ambulatory Surgical Centers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Biodegradable Stents Market, By Region, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2017 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.S.
• Canada
o Europe
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Middle East
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
o Africa
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Boston Scientific Corporation*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Abbott
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Kyoto Medical Planning Co., Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o QualiMed
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Elixir Medical Corporation
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o ENDOCOR GmbH
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o BIOTRONIK SE & Co. KG
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Amaranth Medical, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Arterial Remodeling Technologies SA
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 32 market data tables and 30 figures on "Biodegradable Stents Market - Global forecast to 2026".
Request Discount 
Inquire Before Buy
